• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Eiger Biopharmaceuticals - Articles and news items

Results of Phase 2 study of lonafarnib in HDV infected patients published

Industry news / 20 July 2015 / Victoria White

Results of the first Phase 2a study of lonafarnib in patients with chronic hepatitis delta virus (HDV) infection have been published…